Imugene LtdASX: IMU

Quarterly Activities/Appendix 4C Cash Flow Report

Oct 29, 2026 at 6:43 PM EDT · Issued by Imugene Ltd via ASX

Filed with ASX · Oct 29, 2026 at 6:43 PM EDT

On 6ix: 6ix.com/news/quarterly-activitiesappendix-4c-cash-flow-report-667

ASX: IMU QUARTERLY ACTIVITIES & APPENDIX 4C CASH REPORT Quarter Ended: 30 September 2026 Imugene Limited ABN 99 009 179 551 www.imugene.com ASX Announcement Quarterly Activities and Business Update Quarter ended 30 September 2026 • Azer-cel Phase 1b trial progresses with multiple new complete and...

View Attachment

6ix is reading this filing.

Imugene Ltd on 6ix

Earlier from Imugene

Further Responses in azer-cel Phase 1b TrialOct 18
azer-cel BTKi Cohort Reports new Complete & Partial ResponseOct 4
Third response in concurrent BTKi Cohort of azer-cel TrialJul 26
$11.1 Million Placement Completed to Advance azer-celJul 6
New Complete Response in the Concurrent BTKi azer-cel CohortJun 30

All Imugene news releases

Follow Imugene into a list and get an email when it puts out news.

Follow Imugene